title: [Porphyria induced by valproic acid: clinical case].
abstract: A 47 year-old woman with juvenile myoclonic epilepsy received anticonvulsant therapy with valproate, 200 mg 4 times a day. Severe abdominal pain and vomiting developed 3 days after initiation of therapy, and she became comatose requiring artificial ventilation. Increased urinary output of delta-amino-levulinic acid (48 uM/24 hr, 8 times normal) and porphobilinogen (9 uM/24 hr, twice normal) were demonstrated. Complete recovery took place 5 days after discontinuation of valproate.
authors.affiliation: Servicio de Neurología, P Universidad Católica de Chile, Hospital Dr Sótero del Río, Santiago.
authors.forename: P
authors.initials: P
authors.lastname: Jalil
authors.forename: F
authors.initials: F
authors.lastname: Vergara
mesh_terms: D005260:Female; D006801:Humans; D008875:Middle Aged; D011164:Porphyrias / Q000139:chemically induced*; D014635:Valproic Acid / Q000009:adverse effects*
chemical_list: D014635:Valproic Acid
vernacular_title: Porfiria inducida por valproato: caso clínico.